Company Overview
Snapshot
Founded in January 2018 by Ofer Segal, Kineticann operates with 1–10 employees. The company has raised $805K across one funding round. In August 2021, Kineticann secured funding from PipelBiz.
Business overview
Kineticann develops and manufactures cannabis, terpenes, and food ingredients for the functional food and beverage industry. The company utilizes proprietary technology and innovations to create products for oral consumption, serving the Agriculture & Food Technologies sector, specifically within Food Tech and Medical Cannabis markets. Kineticann's business model is B2B, targeting healthcare, laboratories, pharmaceuticals, and recreational cannabis consumers across Asia, Europe, and South America.
Strategic signal
In October 2017, Kineticann, then known as Kaneh-B, formed a strategic partnership with Yom Chai to conduct scientific clinical trials on ADHD and distribute approved European dermal products. This collaboration signaled an early focus on therapeutic applications and market expansion for the company's offerings, highlighting its commitment to scientific validation and broader product reach within the health and wellness industry.
Log in to access full profile ›Company Intelligence Q&A
- When was Kineticann founded?
- Kineticann was founded in January 2018 by Ofer Segal.
- What is Kineticann's primary focus?
- Kineticann primarily focuses on developing and manufacturing cannabis, terpenes, and food ingredients for the functional food and beverage industry using proprietary technology.
- What was a key strategic partnership for Kineticann?
- In October 2017, Kineticann (then Kaneh-B) formed a strategic partnership with Yom Chai to conduct scientific clinical trials on ADHD and distribute approved European dermal products.
- Which markets does Kineticann serve?
- Kineticann serves geomarkets in Asia, Europe, and South America, targeting healthcare, laboratories, pharmaceuticals, and recreational cannabis consumers.